The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Aloprim
Allopurinol · ALLOPURINOL SODIUM 500 mg/25mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Mylan Institutional LLC
NDC 67457-0187-50 · 1 VIAL, GLASS in 1 CARTON / 25 mL in 1 VIAL, GLASS · NDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Medicare Part B pays (ASP+6%)$4.07per billing unit (1 MG)HCPCS J0206 · Jul 1, 2026
- Part D plans paid (avg)$0.1286per dosage unitgross, before rebates — matched by drug name · 2024
- Federal ceiling (Big4)$1,382.06per unitMylan Institutional LLC · Jan 1, 2026
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$3,987.06
Reported to Texas DSHS · 2026 annual filing · Mylan Institutional Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1 MG
$4.074
HCPCS J0206 · Jul 1, 2026 quarter · typically ASP + 6%
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $9.91 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA020298
- TE code
- AP
- Approval date
- May 17, 1996
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class II · TerminatedMay 5, 2020Mylan Institutional LLC — Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.
Manufacturers of Allopurinol (Injection, Powder, Lyophilized, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fresenius Kabi USA, LLC | ALLOPURINOL SODIUM 500 mg/25mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | ALLOPURINOL SODIUM 500 mg/25mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | ALLOPURINOL SODIUM 500 mg/25mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Aloprim — NDC 67457-0187-50," retrieved September 3, 2026, https://drugdashboards.com/drug/67457018750.
Free to cite with attribution — see how the data is put together.